PanCareSurPass Project HL7 FHIR Implementation Guide
0.1.0 - trial-use
150
PanCareSurPass Project HL7 FHIR Implementation Guide
0.1.0 - trial-use
150
This page is part of the PanCareSurPass Project HL7 FHIR Implementation Guide (v0.1.0: QA Preview) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions 
| Active as of 2023-01-26 |
Definitions for the RelapseAfterFLT logical model.
Guidance on how to interpret the contents of this table can be found here.
| 1. RelapseAfterFLT | |
| Definition | Progression-Relapse after FLT Maturity Level: 2 - Ready for Review |
| Control | 0..? |
| 2. RelapseAfterFLT.identifier | |
| Definition | Progressive number of progression/relapse (1=first; 2= second; 3 = third; ?) after the end of treatment. In this field must be reported the ordinal number of the progression/relapse after the end of treatment. |
| Note | This is a business identifier, not a resource identifier (see discussion) |
| Control | 0..1 |
| Type | Identifier |
| 3. RelapseAfterFLT.relatedDiagnosis | |
| Definition | Progressive number of diagnosis (1=first; 2= second; 3 = third; ?). |
| Control | 0..1 |
| Type | Identifier |
| 4. RelapseAfterFLT.date | |
| Definition | Report here the date (dd/mm/yyyy ) of the relapse/progression. If the date is unkown or partially missed insert the year at the best of your knowledge. |
| Control | 0..1 |
| Type | date |
| 5. RelapseAfterFLT.relapseOrProgression | |
| Definition | Report here if a relapse or progression occurred after the elective end of therapies. Please note that 'progressions' may occurr since in some cases (e.g. stage 3 unoperable residual neuroblastoma or residual CNS tumor) that were considered as 'non active' may progress 1 => Relapse 2 => Progression -9922= > NK |
| Control | 0..1 |
| Type | CodeableConcept |
| 6. RelapseAfterFLT.type | |
| Definition | Please define if the relapse/progression was local, distant or combined. |
| Control | 0..1 |
| Type | CodeableConcept |
| 7. RelapseAfterFLT.site | |
| Definition | Please define if the relapse/progression was local, distant or combined. |
| Control | 0..1 |
| Type | string |
Guidance on how to interpret the contents of this table can be found here.
| 1. RelapseAfterFLT | |
| Definition | Progression-Relapse after FLT Maturity Level: 2 - Ready for Review |
| Control | 0..* |
| 2. RelapseAfterFLT.identifier | |
| Definition | Progressive number of progression/relapse (1=first; 2= second; 3 = third; ?) after the end of treatment. In this field must be reported the ordinal number of the progression/relapse after the end of treatment. |
| Note | This is a business identifier, not a resource identifier (see discussion) |
| Control | 0..1 |
| Type | Identifier |
| 3. RelapseAfterFLT.relatedDiagnosis | |
| Definition | Progressive number of diagnosis (1=first; 2= second; 3 = third; ?). |
| Control | 0..1 |
| Type | Identifier |
| 4. RelapseAfterFLT.date | |
| Definition | Report here the date (dd/mm/yyyy ) of the relapse/progression. If the date is unkown or partially missed insert the year at the best of your knowledge. |
| Control | 0..1 |
| Type | date |
| 5. RelapseAfterFLT.relapseOrProgression | |
| Definition | Report here if a relapse or progression occurred after the elective end of therapies. Please note that 'progressions' may occurr since in some cases (e.g. stage 3 unoperable residual neuroblastoma or residual CNS tumor) that were considered as 'non active' may progress 1 => Relapse 2 => Progression -9922= > NK |
| Control | 0..1 |
| Type | CodeableConcept |
| 6. RelapseAfterFLT.type | |
| Definition | Please define if the relapse/progression was local, distant or combined. |
| Control | 0..1 |
| Type | CodeableConcept |
| 7. RelapseAfterFLT.site | |
| Definition | Please define if the relapse/progression was local, distant or combined. |
| Control | 0..1 |
| Type | string |
Guidance on how to interpret the contents of this table can be found here.
| 1. RelapseAfterFLT | |
| Definition | Progression-Relapse after FLT Maturity Level: 2 - Ready for Review |
| Control | 0..* |
| 2. RelapseAfterFLT.identifier | |
| Definition | Progressive number of progression/relapse (1=first; 2= second; 3 = third; ?) after the end of treatment. In this field must be reported the ordinal number of the progression/relapse after the end of treatment. |
| Note | This is a business identifier, not a resource identifier (see discussion) |
| Control | 0..1 |
| Type | Identifier |
| 3. RelapseAfterFLT.relatedDiagnosis | |
| Definition | Progressive number of diagnosis (1=first; 2= second; 3 = third; ?). |
| Control | 0..1 |
| Type | Identifier |
| 4. RelapseAfterFLT.date | |
| Definition | Report here the date (dd/mm/yyyy ) of the relapse/progression. If the date is unkown or partially missed insert the year at the best of your knowledge. |
| Control | 0..1 |
| Type | date |
| 5. RelapseAfterFLT.relapseOrProgression | |
| Definition | Report here if a relapse or progression occurred after the elective end of therapies. Please note that 'progressions' may occurr since in some cases (e.g. stage 3 unoperable residual neuroblastoma or residual CNS tumor) that were considered as 'non active' may progress 1 => Relapse 2 => Progression -9922= > NK |
| Control | 0..1 |
| Type | CodeableConcept |
| 6. RelapseAfterFLT.type | |
| Definition | Please define if the relapse/progression was local, distant or combined. |
| Control | 0..1 |
| Type | CodeableConcept |
| 7. RelapseAfterFLT.site | |
| Definition | Please define if the relapse/progression was local, distant or combined. |
| Control | 0..1 |
| Type | string |
IG © 2021+ PanCareSurPass Project. Package hl7.eu.fhir.pcsp#0.1.0 based on FHIR 4.0.1. Generated 2023-01-26
Links: Table of Contents |
QA Report
The PanCareSurPass Research and Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 899999.
